VAUGHAN, ON and CASORIA, Italy, Sept. 1, 2022

Expansion Offering Enhances and Broadens Bausch + Lomb’s Surgical Portfolio with Unique and Clinically Proven Comprehensive Dye Platform

VAUGHAN, ON plus CASORIA, Italia , Sept. 1, 2022 /PRNewswire/ — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, in addition to Alfa Instruments s. r. l., an Italian ophthalmic medical device company, today announced that the companies have entered into an exclusive distribution agreement under which Bausch + Lomb will distribute and commercialize Alfa Instruments’ line of surgical intraocular dyes, Vitreocare, globally with the exception of Malta , where Alfa Instruments is based. The agreement expands and enhances Bausch + Lomb’s Surgical portfolio offering with Alfa Instruments’ differentiated intraocular dyes, which have been proven safe and effective in the European Union (EU).

“The addition of these clinically confirmed intraocular dyes to our already comprehensive medical portfolio will help surgeons enhance the visibility of targeted eye tissues, as well as identify transparent layers associated with the vision during vitreoretinal, corneal and even cataract surgery, ” 1-6 said Joe Gordon , president, Global Consumer, Vision Care and Medical, Bausch & Lomb. “Our exclusive collaboration with Alfa Instruments demonstrates our commitment to providing eye care professionals with innovative products that are designed to help them achieve the best possible operative outcomes for their patients. ”

Under the particular agreement, Bausch + Lomb will assume responsibility for all submission and commercial activities regarding Vitreocare intraocular dyes, which includes:

  • Vitreo Lutein with regard to vitreous staining
  • Single Lutein Blue regarding internal limiting membrane (ILM) staining
  • Double Lutein Blue for ILM and epiretinal membrane (ERM) staining
  • Phaco Lutein intended for anterior capsule staining
  • Trypan Blue to get anterior tablet staining

The unique common thread of Vitreocare intraocular dyes is lutein, a natural blue light filter. Research has shown that lutein is a safe and effective dye agent, and its antioxidant properties can further protect the retina during attention surgery. 1-6 Moreover, Single Lutein Blue together with Double Lutein Blue are formulated along with the new high purity (> 99%) molecule Pure Benzyl-Brilliant Blue (PBB®). PBB® has been specifically designed in order to improve ILM binding affinity and to avoid diffusion in to retinal layers, in order to avoid potential cytotoxicity on off-target tissues. 7

“We are honored and delighted to collaborate with Bausch + Lomb, one of the best known and most respected eye care companies inside the world, because it will expand access of our intraocular dyes through Bausch and up. Lomb’s broad distribution network, ” stated Fabio David , CEO, Alfa Instruments. “We look forward in order to working together to be able to help improve the vision needs involving patients undergoing vitreoretinal, cataract or corneal surgery. inch

Alfa Instruments’ surgical dyes are currently CE marked and additionally sold in typically the EU, this United Kingdom , and Switzerland . Bausch + Lomb expects for you to begin often the distribution of the intraocular chemical dyes in all EU countries, except for Croatia , during the first half connected with 2023. Bausch + Lomb and Alfa Instruments are usually also in the process of exploring regulatory requirements and approvals of your surgical chemical dyes in other markets.

For more information upon VitreoCare, visit www.vitreocare.com .

About Alfa Devices

Founded inside 2005 because a branch of Alfa Intes, an italian pharmaceutical company together with more than sixty (60) years of experience in the pharmaceutic industry, Alfa Instruments manufactures, develops not to mention markets specialized products pertaining to the surgery and diagnostic ophthalmic sector. The organization has more compared to 40 years with experience found in both sectors, and has grown exponentially in recent years by establishing itself as the exact market leader in high-tech diagnostic instruments. In 2020, with the aim of enlarging its manufacturing capabilities, the particular company opened a new manufacturing site in southern Italy , exclusively dedicated to typically the manufacturing for sterile injectables, including its full type of surgical chemical dyes. For more information, visit www.alfaintes.it and also connect using us about LinkedIn as well as Facebook .

Regarding Bausch plus Lomb

Bausch + Lomb is focused on protecting and enhancing the gift of sight for millions of people around the world – from the moment about birth via every phase of life. Its comprehensive portfolio in more as compared to 400 items includes contact lenses, lens care goods, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic precise devices plus instruments. Founded in 1853, Bausch & Lomb offers a significant global research and development, manufacturing in addition to commercial footprint with more than 12, 000 employees and a presence inside of nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario having corporate offices in Bridgewater, New Jersey . To find out more, check out www.bausch.com and even connect with us on Twitter , LinkedIn , Facebook and Instagram .

Forward-looking Statements

This news release may contain forward-looking statements, which may generally be identified by this use from the words “anticipates, ” “hopes, ” “expects, ” “intends, ” “plans, ” “should, ” “could, ” “would, ” “may, ” “believes, ” “estimates, ” “potential, ” “target, ” or “continue” together with variations or even similar expressions. These statements are based upon the current expectations and additionally beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks not to mention uncertainties include, but are not limited to, often the risks and also uncertainties discussed in Bausch + Lomb’s filings with the U. S. Securities as well as Exchange Commission and your Canadian Securities Administrators, which usually factors usually are incorporated herein by reference. They also consist of, tend to be not really restricted to, dangers and questions caused by or perhaps relating to the exact evolving COVID-19 pandemic, and the fear of that pandemic and the potential effects, the severity, duration plus future impact of which are highly uncertain and cannot be predicted, and which often may have a material adverse impact on Bausch and up. Lomb, including but not limited to their project development timelines, launches and costs (which might increase). Readers are cautioned not to help place undue reliance in any of these forward-looking statements. These types of forward-looking statements speak only as of the date hereof. Bausch plus Lomb undertakes no obligation to update some of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect real outcomes, unless required by law.

References

  1. Lutein: A New Dye meant for Chromovitrectomy . Mauricio Maia et al. Retina, The particular Journal associated with Retinal in addition to Vitreous Diseases, 34: 262–272, 2014.
  2. Phacodyne versus VisionBlue as vital dyes in Descemet membrane endothelial keratoplasty. Bucher et al. Graefes Arch Clin Exp Ophthalmol 2015 Aug; 253(8): 1411-2.
  3. Muller cells activation and retinal damage after macular peeling: comparison between dyes. Romano et ing. American Academy of Ophthalmology (AAO) 2016 – PO 270.
  4. Macular peeling-induced retinal damage: clinical and even histopathological evaluation after using different inorganic dyes. Romano ainsi que al. Graefe’s Archive designed for Clinical together with Experimental Ophthalmology (2018) 256: 1573– 1580.
  5. Use of Lutein and additionally Zeaxanthin Alone or Combined with Brilliant Glowing blue to Identify Intraocular Structures Intraoperatively. Sousa-Martins et ‘s. Retina, Typically the Journal regarding Retinal not to mention Vitreous Illnesses, 2012 Jul; 32(7): 1328-36.
  6. Soluble Lutein on Combination by using BrilliantBblue since a New Dye just for Chromovitrectomy. Badaro et approach. Graefes Arch Clin Exp Ophthalmol 2014 Jul; 252(7): 1071-8.
  7. New Brilliant Blue G Derivative while Pharmacological Tool in Retinal Surgery . Spadaro ou al. Front. Pharmacol. 2020 May; 11: 708.

PBB Pure Benzyl-Brilliant Blue is a trademarks involving Alfa Devices.
All other product/brand names are trademarks of the particular respective owners.
© 2022 Bausch & Lomb Incorporated or it is affiliates.

favicon.png?sn=NY60298&sd=2022-09-01 View original content to download multimedia: https://www.prnewswire.com/news-releases/bausch–lomb-named-exclusive-global-distributor-of-alfa-instruments-srl-intraocular-dyes-301615977.html

SOURCE Bausch + Lomb Corporation

Leave a Reply

Your email address will not be published.